+Search query
-Structure paper
Title | Orally Bioavailable Dopamine D1/D5 Receptor-Biased Agonists to Study the Role of β-Arrestin in Treatment-Related Dyskinesia in Parkinson's Disease. |
---|---|
Journal, issue, pages | J Med Chem, Vol. 68, Issue 13, Page 13532-13561, Year 2025 |
Publish date | Jul 10, 2025 |
![]() | Rosa María Rodríguez Sarmiento / Stefan Berchtold / Nenad Manevski / Lothar Lindemann / Fabian Dey / Thomas Clairfeuille / Davide Amendola / Nicolas Vautrelle / Venceslas Duveau / Eoin C O Connor / ![]() ![]() |
PubMed Abstract | Dopamine replacement therapies for Parkinson's disease often produce dyskinesias with long-term use. Published studies suggest that introducing β-arrestin signaling might be protective for ...Dopamine replacement therapies for Parkinson's disease often produce dyskinesias with long-term use. Published studies suggest that introducing β-arrestin signaling might be protective for dyskinesia. We advanced known noncatecholamine D1/D5 receptor G protein-biased agonists and found that removal of oxygen in the linker from published compounds limited β-arrestin recruitment, whereas introduction of nitrogen on the central -phenyl linker favored β-arrestin recruitment and provided orally bioavailable compounds. Cryogenic electron microscopy suggested key receptor-ligand interactions influencing the different bias behaviors. We discovered compound , a D1/D5 receptor agonist with β-arrestin recruitment and properties for use . We compared with tavapadon, which shows weak efficacy for β-arrestin signaling, in a rat model of Parkinson's disease with L-DOPA-induced dyskinesias. At particular doses, compound produced efficacy comparable to L-DOPA, but with fewer concomitant dyskinesias. This first study suggests that β-arrestin may have a positive influence on reducing dyskinesias following acute administration. |
![]() | ![]() ![]() |
Methods | EM (single particle) |
Resolution | 2.72 - 2.8 Å |
Structure data | EMDB-52624, PDB-9i52: EMDB-52625, PDB-9i54: |
Chemicals | ![]()
PDB-1izu: M30L/F46L mutant of bovine pancreatic ribonuclease A ![]() ChemComp-HOH: ![]()
PDB-1izv: M30L/F46V mutant of bovine pancreatic ribonuclease A |
Source |
|
![]() | HORMONE / D1R / GS / AGONIST / PARKINSON / NEUROSCIENCE / D1R GS |